Kilpest India gets USFDA’s grant for multiplex real-time PCR test

19 Jun 2020 Evaluate

US Food and Drug Administration (USFDA) has granted emergency use authorization (EUA) to Kilpest India with its subsidiary -- 3B Blackbio Biotech India for its multiplex real-time PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

With this, 3B Blackbio Biotech India becomes first ever Indian molecular diagnostics company to receive US FDA-(EUA). Especially at times when more and more reliable testing is the need of the hour for India as well as other countries, TRUPCR will be reliable options for labs across the globe to perform the molecular testing for Covid-19 suspected individuals.

Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.

3B Blackbio Dx Share Price

765.50 -27.75 (-3.50%)
18-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
UPL 481.00
BASF India 3620.90
PI Industries 3729.95
Bayer CropScience 5558.90
Sumitomo Chemical India 399.65
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.